The Role of Different Molecular Markers in Papillary Thyroid Cancer Patients with Acromegaly


Keskin F. E. , Ozkaya H. M. , Ferahman S. , Haliloglu O., Karatas A., Aksoy F. , ...Daha Fazla

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.127, ss.437-444, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 127 Konu: 7
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1055/a-0629-9223
  • Dergi Adı: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Sayfa Sayıları: ss.437-444

Özet

Purpose Prevalence of papillary thyroid cancer (PTC) is increased in patients with acromegaly. We aimed to determine the protein expression of BRAF, RAS, RET, insulin like growth factor 1(IGF1), Galectine 3, CD56 in patients with PTC related acromegaly and to compare the extensity of these expressions with normal PTC patients and benign thyroid nodules.